£11.0M
The company secured an £11m convertible loan to scale manufacturing and commercial operations for its point-of-care diagnostic system.
QuantuMDx Group
QuantuMDx Group develops point-of-care molecular diagnostic systems.
£11.0MTotal raised
QuantuMDx Group is a life sciences business developing molecular diagnostic technologies for point-of-care testing. Its portable Q-POC system delivers rapid test results for pathogens including SARS-CoV-2.
Categories
Founders
JO
Jonathan O’Halloran
Co-founder and Chief Executive